๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

โœ Scribed by Herbert Riechelmann; Alexander Sauter; Wolfram Golze; Gertraud Hanft; Carsten Schroen; Karl Hoermann; Thomas Erhardt; Silke Gronau


Book ID
113832964
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
522 KB
Volume
44
Category
Article
ISSN
1368-8375

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES